The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGolden Rock Regulatory News (GCG)

  • This share is currently suspended. It was suspended at a price of 3.05

Share Price Information for Golden Rock (GCG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.05
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.05
GCG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Extension of Debt facility

13 Dec 2023 12:54

RNS Number : 6780W
Golden Rock Global PLC
13 December 2023
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, WITHIN, INTO OR IN, THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, THE REPUBLIC OF IRELAND OR JAPAN.

 

13 December 2023,

 

Golden Rock Global PLC

Extension of Debt Facility

Golden Rock Global PLC (LSE:GCG) ("GRG") announces the extension of the terms of existing convertible loan notes ("Loan Notes").

On 5 December 2022, GRG issued Loan Notes to Wei Chen, a director, for aggregate gross proceeds of £100,000. The Loan Notes were unsecured, pay a coupon of 12%, and had a conversion price of 3.125p per share and a maturity date of 1 December 2023 ("Maturity Date"). During the period interest has accrued and not been paid.

At the time the Loan Notes were issued GCG was negotiating a transaction with a third party which would constitute a reverse takeover ("RTO") (as defined in rule 5.6.4 of the Listing Rules of the Financial Conduct Authority ("FCA"). Conversion of the Loan Notes were conditional on re-admission of the Company's entire issued share capital to the standard listing segment of the Official List by the Financial Conduct Authority and to trading of the Main Market of the London Stock Exchange plc. These negotiations subsequently ceased, the suspension to trading was lifted and GCG raised further funds as announced on 20 July 2023. As announced on 17 August 2023, GCG is currently in negotiations to acquire 2mee Limited, which would also constitute an RTO. This transaction is progressing in accordance with management's expectations.

The Board is carefully managing the Company's cash position but is unable to repay the Loan Notes. Wei Chen has agreed with the Company to extend the maturity date of the Loan notes to 30 June 2024 with all other conditions remaining the same. No fee has been paid as a consequence of the extension.

 

Further Information:

Ross Andrews

Chairman, Golden Rock Global

Email: ross.andrews@rmaconsultancy.co.uk

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFLFEFFLLVLIV
12
Date   Source Headline
13th Dec 202312:54 pmRNSExtension of Debt facility
29th Sep 20237:00 amRNSHalf-year Report
17th Aug 20237:39 amRNSProposed Transaction and Suspension of Listing
17th Aug 20237:30 amRNSSuspension - Golden Rock Global plc
26th Jul 20239:44 amRNSHolding(s) in Company
20th Jul 20234:36 pmRNSDirector/PDMR Shareholding
20th Jul 20237:00 amRNSFundraising and Broker Appointment
19th Jul 20237:00 amRNSUpdate on Potential Acquisition
28th Jun 20237:00 amRNSStmnt re Share Price Movement
12th Jun 20237:00 amRNSResult of AGM
28th Apr 20233:29 pmRNSAnnual Financial Report
5th Apr 20233:11 pmRNSRestoration of Trading
5th Dec 20227:00 amRNSIssue of Debt
18th Oct 20227:00 amRNSHalf-year Report
30th Sep 20223:46 pmRNSResult of AGM
14th Jun 20227:00 amRNSFinal Results
17th Nov 20217:40 amRNSStatement re. Suspension
16th Nov 20214:40 pmRNSSecond Price Monitoring Extn
16th Nov 20214:35 pmRNSPrice Monitoring Extension
16th Nov 20212:05 pmRNSSecond Price Monitoring Extn
16th Nov 20212:00 pmRNSPrice Monitoring Extension
15th Nov 202111:05 amRNSSecond Price Monitoring Extn
15th Nov 202111:00 amRNSPrice Monitoring Extension
12th Nov 20212:27 pmRNSHolding(s) in Company
26th Oct 20214:35 pmRNSHolding(s) in Company
27th Sep 20213:20 pmRNSHalf-year Report
20th Jul 202112:32 pmRNSResult of AGM
18th Jun 202110:30 amRNSNotice of AGM
7th May 20218:35 amRNSFinal Results
15th Apr 20212:06 pmRNSSecond Price Monitoring Extn
15th Apr 20212:01 pmRNSPrice Monitoring Extension
15th Mar 20214:41 pmRNSSecond Price Monitoring Extn
15th Mar 20214:35 pmRNSPrice Monitoring Extension
12th Mar 20212:05 pmRNSSecond Price Monitoring Extn
12th Mar 20212:00 pmRNSPrice Monitoring Extension
12th Mar 202111:06 amRNSSecond Price Monitoring Extn
12th Mar 202111:00 amRNSPrice Monitoring Extension
10th Mar 20214:00 pmRNSUpdate to Fundraising and expected Admission Date
8th Mar 20212:06 pmRNSSecond Price Monitoring Extn
8th Mar 20212:00 pmRNSPrice Monitoring Extension
8th Mar 202111:06 amRNSSecond Price Monitoring Extn
8th Mar 202111:00 amRNSPrice Monitoring Extension
5th Mar 20214:40 pmRNSSecond Price Monitoring Extn
5th Mar 20214:36 pmRNSPrice Monitoring Extension
5th Mar 20212:05 pmRNSSecond Price Monitoring Extn
5th Mar 20212:00 pmRNSPrice Monitoring Extension
23rd Feb 20214:33 pmRNSFundraising and Board Changes
10th Feb 202111:06 amRNSSecond Price Monitoring Extn
10th Feb 202111:00 amRNSPrice Monitoring Extension
10th Feb 20219:06 amRNSSecond Price Monitoring Extn
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.